Erbitux®
offering product urn:matchory:offering:01m772jrp3ev2tehqqd9dj17bj
Offered by Merck KGaA urn:matchory:entity:01m772jn56e8d8bm4fgqy5z569 (entity). Relation: not stated. Commodity: none confirmed.
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | Erbitux® | products products 2 | Merck announced that the European Commission (EC) approved an update to the Erbitux (cetuximab) EU label on June 26, 2026.https://web.archive.org/web/20261014060532id_/https://www.merckgroup.com/en/expertise/healthcare.html |
2026-10-05 | current |
| Name as stated name | Erbitux® | extraction extract 3 | Erbitux®https://web.archive.org/web/20261014060532id_/https://www.merckgroup.com/en/expertise/healthcare.html |
2026-10-05 | current |
| UNSPSC classification unspsc | no code (16 candidates considered) | classification unspsc 3 | 2026-11-12 | current |